Cardiology
RSSArticles
-
Does Fludrocortisone Work in Vasovagal Syncope?
A multicenter, randomized, double-blind, controlled trial of fludrocortisone at a range of doses in patients with recurrent vasovagal syncope showed an overall trend toward reduced syncope, which was statistically significant in those who achieved the 0.2 mg daily dose.
-
Management of Oral Anticoagulation in Atrial Fibrillation Patients with Worsening Renal Function
Approximately 25% of atrial fibrillation patients in a large trial comparing rivaroxaban to warfarin developed worsening renal failure during follow-up. Those treated with rivaroxaban had less embolic events, but equal bleeding events compared to those on warfarin.
-
Take Two, and Call Me in the Morning?
In a real-world population of atrial fibrillation patients at moderate to high risk of stroke, more than one-third were treated with aspirin as opposed to an oral anticoagulant. Those with conditions related to coronary heart disease were more likely to be treated with aspirin.
-
Proportional Assist Ventilation and Lung Protection in Acute Respiratory Distress Syndrome: A Way Forward
A post-hoc analysis found that once patients were allowed to control their breathing pattern on high-level proportional assist ventilation, they continued to maintain an estimated driving pressure remarkably close to that measured during lung protective ventilation.
-
How Good Is Passive Leg Raise at Predicting Fluid Responsiveness?
In a meta-analysis of 23 clinical trials, passive leg raise was shown to be an excellent predictor of fluid responsiveness.
-
ICU Outcomes and Triage in Elderly Patients with Advanced Cancer
Here are the stats for those patients who are 80 years and older.
-
Is This ECG Normal for Age?
The seemingly tall lateral chest lead R waves are not outside the normal range for a child this age.
-
Clinical Briefs
In this section: effects of testosterone treatment in older men; liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis; and long-acting anticholinergics and beta agonists for COPD.
-
Daclizumab Injection (Zinbryta)
Another option for the treatment of the relapsing form of multiple sclerosis.
-
The Current Outlook for Cardiac Tamponade
In the modern era, cardiac tamponade is most commonly caused by malignancies with poor prognosis. As compared to older literature, iatrogenic causes have increased, most resulting from complications of percutaneous coronary intervention.